{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:31:35Z","timestamp":1794378695057,"version":"4.9.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.semarthrit.2008.01.015","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T20:11:59Z","timestamp":1208808719000},"page":"372-381","source":"Crossref","is-referenced-by-count":134,"title":["Lipid Profiles in Patients with Rheumatoid Arthritis: Mechanisms and the Impact of Treatment"],"prefix":"10.1016","volume":"38","author":[{"given":"George","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray B.","family":"Urowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.01.015_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semarthrit.2005.03.004","article-title":"Rheumatoid arthritis: a disease associated with accelerated atherogenesis","volume":"35","author":"Gonzalez-Gay","year":"2005","journal-title":"Sem Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention","volume":"8","author":"Li","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbspin.2006.10.001","article-title":"Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France","volume":"74","author":"Assous","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","article-title":"Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study","volume":"63","author":"Turesson","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib8","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ard.2004.034777","article-title":"Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s","volume":"64","author":"Goodson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib9","doi-asserted-by":"crossref","first-page":"R984","DOI":"10.1186\/ar1775","article-title":"Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study","volume":"7","author":"Warrington","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib11","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects","volume":"48","author":"del Rincon","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib12","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib13","doi-asserted-by":"crossref","unstructured":"NCEP. Third report of the National Cholesterol Education Program (NCEP) expert panel on: Detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Executive Summary. NIH Publication no. 01-3670. May 2001.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/ard.2006.053488","article-title":"Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study","volume":"66","author":"Karvounaris","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/105072504323150750","article-title":"Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis","volume":"14","author":"Dessein","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib17","first-page":"2425","article-title":"Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis","volume":"33","author":"Dessein","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib18","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.22053","article-title":"Insulin resistance and impaired beta cell function in rheumatoid arthritis","volume":"54","author":"Dessein","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.rdc.2005.01.006","article-title":"Inflammation and accelerated atherosclerosis: basic mechanisms","volume":"31","author":"Doria","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.CIR.0000129507.12719.80","article-title":"CRP as a mediator of disease","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00296-007-0357-y","article-title":"Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis","volume":"27","author":"Emery","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib23","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2005.08.010","article-title":"Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis","volume":"365","author":"Allanore","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1351.039","article-title":"Effects of anti-TNF-a treatment on lipid profile in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jc.85.3.1334","article-title":"Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects","volume":"85","author":"Fernandez-Real","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbalip.2005.08.003","article-title":"High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli","volume":"1736","author":"Gomaraschi","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI113991","article-title":"Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat: evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia","volume":"83","author":"Feingold","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diabetes.45.7.881","article-title":"Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib33","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis\u2014the Third National Health and Nutrition Examination Survey","volume":"32","author":"Choi","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation","volume":"25","author":"Dursunoglu","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib35","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2014a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib36","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1529-0131(199904)42:3<443::AID-ANR8>3.0.CO;2-Q","article-title":"Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis","volume":"42","author":"Asanuma","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3949\/ccjm.66.8.465","article-title":"Should one routinely screen for lipoprotein(a)?","volume":"66","author":"Frolkis","year":"1999","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib39","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar428","article-title":"Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis","volume":"4","author":"Dessein","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2005.050443","article-title":"Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis","volume":"65","author":"van Halm","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib42","first-page":"1004","article-title":"Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis","volume":"114","author":"Cauza","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib43","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar597","article-title":"Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study","volume":"4","author":"Dessein","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib44","first-page":"867","article-title":"Glucocorticoids and insulin sensitivity in rheumatoid arthritis","volume":"31","author":"Dessein","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.04.031","article-title":"Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol","volume":"177","author":"Irace","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib46","first-page":"921","article-title":"Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Kiortsis","year":"2006","journal-title":"J Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2008.01.015_bib47","article-title":"Lipid profile in patients with active rheumatoid arthritis under infliximab therapy","volume":"64","author":"Kyriazis","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib48","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib50","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2006.059691","article-title":"Changes in lipid profile during infliximab treatment and corticosteroid therapy in rheumatoid arthritis","volume":"66","author":"Peters","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib51","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib52","first-page":"252","article-title":"Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis","volume":"32","author":"Vis","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/keg083","article-title":"Rheumatoid arthritis and macrovascular disease","volume":"42","author":"Alkaabi","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib54","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jacc.2007.01.083","article-title":"Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis","volume":"49","author":"Kinlay","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1160\/TH05-01-0067","article-title":"Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1081\/ERC-200033541","article-title":"The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients","volume":"30","author":"Coban","year":"2004","journal-title":"Endocr Res"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacc.2006.05.009","article-title":"The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study","volume":"48","author":"Muhlestein","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib58","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1210\/jc.2005-1615","article-title":"Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance","volume":"91","author":"Okopien","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2249.2003.02358.x","article-title":"Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation","volume":"135","author":"Fischetti","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib60","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/art.22632","article-title":"Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis","volume":"56","author":"Haruna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib61","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/rheumatology\/keh194","article-title":"Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins","volume":"43","author":"ten Cate","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib63","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib64","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"Maki-Petaja","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib65","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/ard.2003.015008","article-title":"Successful treatment with fenofibrate, a peroxisome proliferator activated receptor alpha ligand, for a patient with rheumatoid arthritis","volume":"63","author":"Okamoto","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000099097","article-title":"Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease","volume":"108","author":"Moon","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.mol.0000236367.42755.c1","article-title":"Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease","volume":"17","author":"Packard","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.semarthrit.2008.01.015_bib68","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(04)16485-4","article-title":"Statins in rheumatoid arthritis\u2014two birds with one stone?","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T15:46:17Z","timestamp":1557503177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0049017208000383"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}